Since the initial COVID-19 outbreak, the SARS-CoV-2 virus has mutated, resulting in a range of variants. SARS-CoV-2 variants of concern, exemplified most recently with Omicron, need to be detected early and accurately to ensure confidence in testing results and surveillance efforts.This includes an overview of the current pandemic state, the PCR-based TaqPath COVID-19 diagnostic solution assay design, the S gene target failure, and surveillance solutions in light of Omicron. We will present the current knowledge on the features of the Omicron variant and showcase different strategies that were used around the world to track its spread.
We will further discuss the different approaches for detection, discrimination, and identification of novel SARS-CoV-2 variants using genetic tests. The webinar will provide an overview of surveillance tools which can enable laboratories to scale up surveillance testing and efficiently utilize available resources to fight the ongoing COVID-19 pandemic.
1. Discuss Omicron variant features and significance.
2. Identify differing strategies for surveillance of SARS-CoV-2 variants.
3. Discuss why the most recent, record-breaking surge in COVID-19 cases has increased the demand for rapid, accurate, and sensitive high-volume testing.
4. Discuss cite S gene target failure, why it occurs, and how it can lead to advantage in surveillance efforts
Illustrate the implications of viral mutations.